ArticleJournal of experimental & clinical cancer research : CR2016

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.

Jing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.